{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:40:57Z","timestamp":1777603257060,"version":"3.51.4"},"reference-count":87,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-16-0534","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T15:29:04Z","timestamp":1466609344000},"page":"1665-1673","source":"Crossref","is-referenced-by-count":44,"title":["Patent Foramen Ovale and Stroke"],"prefix":"10.1253","volume":"80","author":[{"given":"Yee-Ping","family":"Sun","sequence":"first","affiliation":[{"name":"Columbia University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Homma","sequence":"additional","affiliation":[{"name":"Columbia University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. <i>Mayo Clin Proc<\/i> 1984; 59: 17\u201320.","DOI":"10.1016\/S0025-6196(12)60336-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, et al. Patent foramen ovale: Innocent or guilty? <i>J Am Coll Cardiol<\/i> 2006; 47: 440\u2013445.","DOI":"10.1016\/j.jacc.2005.10.044"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Schneider B, Zienkiewicz T, Jansen V, Hofmann T, Noltenius H, Meinertz T. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. <i>Am J Cardiol<\/i> 1996; 77: 1202\u20131209.","DOI":"10.1016\/S0002-9149(96)00163-4"},{"key":"4","unstructured":"4. Cohnheim J. Vorlesungen uber allgemenie pathologie. <i>J Thromb Emboli<\/i> 1877; 1: 134 (in German)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Litten M. Pathologisch-anatomisch Beobachtungen I, Ueber einen Fall von infiltriertem Leberkrebs, nebst epikritischen Bemerkungen. II: Ueber embolische Muskelveranderung und die Resorption todter Muskelfasern. <i>Virch Archiv<\/i> 1880; 80: 269\u2013295 (in German).","DOI":"10.1007\/BF01877560"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age: A study using transesophageal echocardiography. <i>Stroke<\/i> 1993; 24: 1865\u20131873.","DOI":"10.1161\/01.STR.24.12.1865"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. <i>Ann Intern Med<\/i> 1992; 117: 461\u2013465.","DOI":"10.7326\/0003-4819-117-6-461"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. <i>N Engl J Med<\/i> 1988; 318: 1148\u20131152.","DOI":"10.1056\/NEJM198805053181802"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, et al. Patent foramen ovale in young stroke patients. <i>Lancet<\/i> 1988; 2: 11\u201312.","DOI":"10.1016\/S0140-6736(88)92944-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. de Belder MA, Tourikis L, Leech G, Camm AJ. Risk of patent foramen ovale for thromboembolic events in all age groups. <i>Am J Cardiol<\/i> 1992; 69: 1316\u20131320.","DOI":"10.1016\/0002-9149(92)91228-V"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hausmann D, Mugge A, Becht I, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. <i>Am J Cardiol<\/i> 1992; 70: 668\u2013672.","DOI":"10.1016\/0002-9149(92)90210-P"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rigatelli G, Ronco F. Patent foramen ovale: A comprehensive review for pulmonologists. <i>Curr Opin Pulm Med<\/i> 2010; 16: 442\u2013447.","DOI":"10.1097\/MCP.0b013e32833b1f78"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Billinge M, Zbinden R, Mordasini R, Windecker S, Schwerzmann M, Meier B, et al. Patent foramen ovale closure in recreational divers: Effect on decompression illness and ischaemic brain lesions during long-term follow-up. <i>Heart<\/i> 2011; 97: 1932\u20131937.","DOI":"10.1136\/heartjnl-2011-300436"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wohrle J, Kochs M, Hombach V, Merkle N. Prevalence of myocardial scar in patients with cryptogenic cerebral ischemic events and patent foramen ovale. <i>JACC Cardiovasc Imaging<\/i> 2010; 3: 833\u2013839.","DOI":"10.1016\/j.jcmg.2010.05.013"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lau EM, Yee BJ, Grunstein RR, Celermajer DS. Patent foramen ovale and obstructive sleep apnea: A new association? <i>Sleep Med Rev<\/i> 2010; 14: 391\u2013395.","DOI":"10.1016\/j.smrv.2010.02.002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rundek T, Elkind MS, Di Tullio MR, Carrera E, Jin Z, Sacco RL, et al. Patent foramen ovale and migraine: A cross-sectional study from the Northern Manhattan Study (NOMAS). <i>Circulation<\/i> 2008; 118: 1419\u20131424.","DOI":"10.1161\/CIRCULATIONAHA.108.771303"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Calvert PA, Rana BS, Kydd AC, Shapiro LM. Patent foramen ovale: Anatomy, outcomes, and closure. <i>Nat Rev Cardiol<\/i> 2011; 8: 148\u2013160.","DOI":"10.1038\/nrcardio.2010.224"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. van Vonderen JJ, Roest AA, Siew ML, Walther FJ, Hooper SB, te Pas AB. Measuring physiological changes during the transition to life after birth. <i>Neonatology<\/i> 2014; 105: 230\u2013242.","DOI":"10.1159\/000356704"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Di Tullio MR. Patent foramen ovale: Echocardiographic detection and clinical relevance in stroke. <i>J Am Soc Echocardiogr<\/i> 2010; 23: 144\u2013155; quiz 220.","DOI":"10.1016\/j.echo.2009.12.008"},{"key":"20","unstructured":"20. Penther P. Patent foramen ovale: An anatomical study: Apropos of 500 consecutive autopsies. <i>Arch Mal Coeur Vaiss<\/i> 1994; 87: 15\u201321 (in French)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rodriguez CJ, Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, et al. Race-ethnic differences in patent foramen ovale, atrial septal aneurysm, and right atrial anatomy among ischemic stroke patients. <i>Stroke<\/i> 2003; 34: 2097\u20132102.","DOI":"10.1161\/01.STR.0000085828.67563.42"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: The Helsinki young stroke registry. <i>Stroke<\/i> 2009; 40: 1195\u20131203.","DOI":"10.1161\/STROKEAHA.108.529883"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. <i>N Engl J Med<\/i> 2007; 357: 2262\u20132268.","DOI":"10.1056\/NEJMoa071422"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. <i>Neurology<\/i> 2013; 81: 619\u2013625.","DOI":"10.1212\/WNL.0b013e3182a08d59"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Di Tullio MR, Jin Z, Russo C, Elkind MS, Rundek T, Yoshita M, et al. Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. <i>J Am Coll Cardiol<\/i> 2013; 62: 35\u201341.","DOI":"10.1016\/j.jacc.2013.03.064"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. <i>J Am Coll Cardiol<\/i> 2007; 49: 797\u2013802.","DOI":"10.1016\/j.jacc.2006.08.063"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Rundek T. PFO in stroke: A direct association or coincidence? <i>Eur J Neurol<\/i> 2008; 15: 887\u2013888.","DOI":"10.1111\/j.1468-1331.2008.02231.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. <i>N Engl J Med<\/i> 2014; 370: 2478\u20132486.","DOI":"10.1056\/NEJMoa1313600"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Thijs VN, Brachmann J, Morillo CA, Passman RS, Sanna T, Bernstein RA, et al. Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF. <i>Neurology<\/i> 2016; 86: 261\u2013269.","DOI":"10.1212\/WNL.0000000000002282"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Lopez MF, Krastins B, Sarracino DA, Byram G, Vogelsang MS, Prakash A, et al. Proteomic signatures of serum albumin-bound proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol efflux. <i>Clin Proteomics<\/i> 2015; 12: 2.","DOI":"10.1186\/1559-0275-12-2"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Lopez MF, Sarracino DA, Vogelsang M, Sutton JN, Athanas M, Krastins B, et al. Heart-brain signaling in patent foramen ovale-related stroke: Differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflow. <i>J Invest Med<\/i> 2012; 60: 1122\u20131130.","DOI":"10.2310\/JIM.0b013e318276de0e"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kronik G, Mosslacher H. Positive contrast echocardiography in patients with patent foramen ovale and normal right heart hemodynamics. <i>Am J Cardiol<\/i> 1982; 49: 1806\u20131809.","DOI":"10.1016\/0002-9149(82)90263-6"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Sharma VK, Tsivgoulis G, Lao AY, Alexandrov AV. Role of transcranial Doppler ultrasonography in evaluation of patients with cerebrovascular disease. <i>Curr Neurol Neurosci Rep<\/i> 2007; 7: 8\u201320.","DOI":"10.1007\/s11910-007-0016-4"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Porter TR, Abdelmoneim S, Belcik JT, McCulloch ML, Mulvagh SL, Olson JJ, et al. Guidelines for the cardiac sonographer in the performance of contrast echocardiography: A focused update from the American Society of Echocardiography. <i>J Am Soc Echocardiogr<\/i> 2014; 27: 797\u2013810.","DOI":"10.1016\/j.echo.2014.05.011"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Di Tullio M, Sacco RL, Massaro A, Venketasubramanian N, Sherman D, Hoffmann M, et al. Transcranial Doppler with contrast injection for the detection of patent foramen ovale in stroke patients. <i>Int J Card Imaging<\/i> 1993; 9: 1\u20135.","DOI":"10.1007\/BF01142927"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Di Tullio M, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. <i>Stroke<\/i> 1993; 24: 1020\u20131024.","DOI":"10.1161\/01.STR.24.7.1020"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Clarke NR, Timperley J, Kelion AD, Banning AP. Transthoracic echocardiography using second harmonic imaging with Valsalva manoeuvre for the detection of right to left shunts. <i>Eur J Echocardiogr<\/i> 2004; 5: 176\u2013181.","DOI":"10.1016\/S1525-2167(03)00076-3"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Daniels C, Weytjens C, Cosyns B, Schoors D, De Sutter J, Paelinck B, et al. Second harmonic transthoracic echocardiography: The new reference screening method for the detection of patent foramen ovale. <i>Eur J Echocardiogr<\/i> 2004; 5: 449\u2013452.","DOI":"10.1016\/j.euje.2004.04.004"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A, Davalos A. The need to quantify right-to-left shunt in acute ischemic stroke: A case-control study. <i>Stroke<\/i> 1998; 29: 1322\u20131328.","DOI":"10.1161\/01.STR.29.7.1322"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Droste DW, Lakemeier S, Wichter T, Stypmann J, Dittrich R, Ritter M, et al. Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. <i>Stroke<\/i> 2002; 33: 2211\u20132216.","DOI":"10.1161\/01.STR.0000027884.03365.AC"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Katsanos AH, Psaltopoulou T, Sergentanis TN, Frogoudaki A, Vrettou AR, Ikonomidis I, et al. Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta-analysis. <i>Ann Neurol<\/i> 2016; 79: 625\u2013635.","DOI":"10.1002\/ana.24609"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Droste DW, Schmidt-Rimpler C, Wichter T, Dittrich R, Ritter M, Stypmann J, et al. Right-to-left-shunts detected by transesophageal echocardiography and transcranial Doppler sonography. <i>Cerebrovasc Dis<\/i> 2004; 17: 191\u2013196.","DOI":"10.1159\/000075790"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Zoghbi WA. Patent foramen ovale: Going beyond the bubbles. <i>JACC Cardiovasc Imaging<\/i> 2014; 7: 251\u2013253.","DOI":"10.1016\/j.jcmg.2014.01.007"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Johansson MC, Helgason H, Dellborg M, Eriksson P. Sensitivity for detection of patent foramen ovale increased with increasing number of contrast injections: A descriptive study with contrast transesophageal echocardiography. <i>J Am Soc Echocardiogr<\/i> 2008; 21: 419\u2013424.","DOI":"10.1016\/j.echo.2007.08.030"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Romero JR, Frey JL, Schwamm LH, Demaerschalk BM, Chaliki HP, Parikh G, et al. Cerebral ischemic events associated with \u2018bubble study\u2019 for identification of right to left shunts. <i>Stroke<\/i> 2009; 40: 2343\u20132348.","DOI":"10.1161\/STROKEAHA.109.549683"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Akhondi A, Gevorgyan R, Tseng CH, Slavin L, Dao C, Liebeskind DS, et al. The association of patent foramen ovale morphology and stroke size in patients with paradoxical embolism. <i>Circ Cardiovasc Interv<\/i> 2010; 3: 506\u2013510.","DOI":"10.1161\/CIRCINTERVENTIONS.109.908533"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA, et al. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. <i>Am J Cardiol<\/i> 2009; 103: 124\u2013129.","DOI":"10.1016\/j.amjcard.2008.08.036"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Wessle BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, et al. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: Analysis of putative high-risk features from the risk of paradoxical embolism database. <i>Circ Cardiovasc Imaging<\/i> 2014; 7: 125\u2013131.","DOI":"10.1161\/CIRCIMAGING.113.000807"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Rigatelli G, Dell\u2019Avvocata F, Cardaioli P, Giordan M, Braggion G, Aggio S, et al. Permanent right-to-left shunt is the key factor in managing patent foramen ovale. <i>J Am Coll Cardiol<\/i> 2011; 58: 2257\u20132261.","DOI":"10.1016\/j.jacc.2011.06.064"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Rigatelli G, Dell\u2019avvocata F, Vassiliev D, Daggubati R, Buch A, Nanjiundappa A, et al. ICE-classification of interatrial septum anatomy in patients with R\u2192L shunt. <i>JACC Cardiovasc Imaging<\/i> 2014; 7: 205\u2013206.","DOI":"10.1016\/j.jcmg.2013.06.010"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Serena J, Marti-Fabregas J, Santamarina E, Rodriguez JJ, Perez-Ayuso MJ, Masjuan J, et al. Recurrent stroke and massive right-to-left shunt: Results from the prospective Spanish multicenter (CODICIA) study. <i>Stroke<\/i> 2008; 39: 3131\u20133136.","DOI":"10.1161\/STROKEAHA.108.521427"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, et al. Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. <i>J Am Soc Echocardiogr<\/i> 2015; 28: 910\u2013958.","DOI":"10.1016\/j.echo.2015.05.015"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Atrial anatomy in non-cardioembolic stroke patients: Effect of medical therapy. <i>J Am Coll Cardiol<\/i> 2003; 42: 1066\u20131072.","DOI":"10.1016\/S0735-1097(03)00907-0"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Schneider B, Hofmann T, Justen MH, Meinertz T. Chiari\u2019s network: Normal anatomic variant or risk factor for arterial embolic events? <i>J Am Coll Cardiol<\/i> 1995; 26: 203\u2013210.","DOI":"10.1016\/0735-1097(95)00144-O"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Kato Y, Dembo T, Takeda H, Fukuoka T, Tanahashi N. Prominent persisting Eustachian valve initiates spontaneous right-to-left shunt and paradoxical embolism in a patient with patent foramen ovale. <i>Neurol Sci<\/i> 2011; 32: 925\u2013926.","DOI":"10.1007\/s10072-011-0567-7"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Cramer SC, Rordorf G, Kaufman JA, Buonanno F, Koroshetz WJ, Schwamm L. Clinically occult pelvic-vein thrombosis in cryptogenic stroke. <i>Lancet<\/i> 1998; 351: 1927\u20131928.","DOI":"10.1016\/S0140-6736(05)78611-6"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Lethen H, Flachskampf FA, Schneider R, Sliwka U, Kohn G, Noth J, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. <i>Am J Cardiol<\/i> 1997; 80: 1066\u20131069.","DOI":"10.1016\/S0002-9149(97)00604-8"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Cramer SC, Rordorf G, Maki JH, Kramer LA, Grotta JC, Burgin WS, et al. Increased pelvic vein thrombi in cryptogenic stroke: Results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. <i>Stroke<\/i> 2004; 35: 46\u201350.","DOI":"10.1161\/01.STR.0000106137.42649.AB"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Liberman AL, Daruwalla VJ, Collins JD, Maas MB, Botelho MP, Ayache JB, et al. Diagnostic yield of pelvic magnetic resonance venography in patients with cryptogenic stroke and patent foramen ovale. <i>Stroke<\/i> 2014; 45: 2324\u20132329.","DOI":"10.1161\/STROKEAHA.114.005539"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Kiernan TJ, Yan BP, Cubeddu RJ, Rengifo-Moreno P, Gupta V, Inglessis I, et al. May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: An important clinical association. <i>Stroke<\/i> 2009; 40: 1502\u20131504.","DOI":"10.1161\/STROKEAHA.108.527366"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Osgood M, Budman E, Carandang R, Goddeau RP Jr, Henninger N. Prevalence of pelvic vein pathology in patients with cryptogenic stroke and patent foramen ovale undergoing MRV pelvis. <i>Cerebrovasc Dis<\/i> 2015; 39: 216\u2013223.","DOI":"10.1159\/000376613"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Lantz M, Sjostrand C, Kostulas K. Ischemic stroke and patent foramen ovale: Risk factors and genetic profile. <i>J Stroke Cerebrovasc Dis<\/i> 2013; 22: 841\u2013845.","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.06.002"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Pezzini A, Grassi M, Zotto ED, Giossi A, Volonghi I, Costa P, et al. Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale?: Systematic review and meta-analysis. <i>Thromb Haemost<\/i> 2009; 101: 813\u2013817.","DOI":"10.1160\/TH08-11-0747"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Favaretto E, Sartori M, Conti E, Legnani C, Palareti G. G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale. <i>Thromb Res<\/i> 2012; 130: 720\u2013724.","DOI":"10.1016\/j.thromres.2012.07.020"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Norata GD, Tsimikas S, Pirillo A, Catapano AL. Apolipoprotein C-III: From pathophysiology to pharmacology. <i>Trends Pharmacol Sci<\/i> 2015; 36: 675\u2013687.","DOI":"10.1016\/j.tips.2015.07.001"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Rajamani K, Chaturvedi S, Jin Z, Homma S, Brey RL, Tilley BC, et al. Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: The PICSS-APASS study. <i>Stroke<\/i> 2009; 40: 2337\u20132342.","DOI":"10.1161\/STROKEAHA.108.539171"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Goldhaber SZ. Risk factors for venous thromboembolism. <i>J Am Coll Cardiol<\/i> 2010; 56: 1\u20137.","DOI":"10.1016\/j.jacc.2010.01.057"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. <i>Stroke<\/i> 2014; 45: 2160\u20132236.","DOI":"10.1161\/STR.0000000000000024"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in Cryptogenic Stroke Study. <i>Circulation<\/i> 2002; 105: 2625\u20132631.","DOI":"10.1161\/01.CIR.0000017498.88393.44"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD. Recurrent cerebral ischemia in medically treated patent foramen ovale: A meta-analysis. <i>Neurology<\/i> 2009; 73: 89\u201397.","DOI":"10.1212\/WNL.0b013e3181aa2a19"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Weimar C, Serena J, et al. Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: An individual participant data meta-analysis. <i>Eur Heart J<\/i> 2015; 36: 2381\u20132389.","DOI":"10.1093\/eurheartj\/ehv252"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Lip GY, Lane DA. Stroke prevention in atrial fibrillation: A systematic review. <i>JAMA<\/i> 2015; 313: 1950\u20131962.","DOI":"10.1001\/jama.2015.4369"},{"key":"73","unstructured":"73. Bayer. Rivaroxaban versus aspirin in secondary prevention of stroke and prevention of systemic embolism in patients with recent embolic stroke of undetermined source (ESUS). 2018. https:\/\/ClinicalTrials.gov\/show\/NCT02313909 (acessed May 30, 2016)."},{"key":"74","unstructured":"74. Boehringer-Ingelheim. Dabigatran etexilate for secondary stroke prevention in patients with embolic stroke of undetermined source (RE-SPECT ESUS). 2017. https:\/\/ClinicalTrials.gov\/show\/NCT02239120 (acessed May 30, 2016)."},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. <i>N Engl J Med<\/i> 2013; 368: 1092\u20131100.","DOI":"10.1056\/NEJMoa1301440"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. <i>N Engl J Med<\/i> 2013; 368: 1083\u20131091.","DOI":"10.1056\/NEJMoa1211716"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. <i>N Engl J Med<\/i> 2012; 366: 991\u2013999.","DOI":"10.1056\/NEJMoa1009639"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, et al. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: A systematic review and meta-analysis. <i>JACC Cardiovasc Interv<\/i> 2013; 6: 1316\u20131323.","DOI":"10.1016\/j.jcin.2013.08.001"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: A systematic review and meta-analysis of randomized controlled trials. <i>Eur Heart J<\/i> 2013; 34: 3342\u20133352.","DOI":"10.1093\/eurheartj\/eht285"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, et al. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: A network meta-analysis. <i>Eur Heart J<\/i> 2015; 36: 120\u2013128.","DOI":"10.1093\/eurheartj\/ehu292"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Udell JA, Opotowsky AR, Khairy P, Silversides CK, Gladstone DJ, O\u2019Gara PT, et al. Patent foramen ovale closure vs medical therapy for stroke prevention: Meta-analysis of randomized trials and review of heterogeneity in meta-analyses. <i>Can J Cardiol<\/i> 2014; 30: 1216\u20131224.","DOI":"10.1016\/j.cjca.2014.05.004"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Pineda AM, Nascimento FO, Yang SC, Kirtane AJ, Sommer RJ, Beohar N. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events. <i>Catheter Cardiovasc Interv<\/i> 2013; 82: 968\u2013975.","DOI":"10.1002\/ccd.25122"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Kitsios GD, Thaler DE, Kent DM. Potentially large yet uncertain benefits: A meta-analysis of patent foramen ovale closure trials. <i>Stroke<\/i> 2013; 44: 2640\u20132643.","DOI":"10.1161\/STROKEAHA.113.001773"},{"key":"84","doi-asserted-by":"publisher","unstructured":"84. Spencer FA, Lopes LC, Kennedy SA, Guyatt G. Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale. <i>BMJ Open<\/i> 2014; 4: e004282, doi:10.1136\/bmjopen-2013-004282.","DOI":"10.1136\/bmjopen-2013-004282"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, et al. Device closure of patent foramen ovale after stroke: Pooled analysis of completed randomized trials. <i>J Am Coll Cardiol<\/i> 2016; 67: 907\u2013917.","DOI":"10.1016\/j.jacc.2015.12.023"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Love BA, Diener HC. PFO: \u201cPlease figure out,\u201d or now \u201cPotentially figured out?\u201d <i>J Am Coll Cardiol<\/i> 2016; 67: 918\u2013920.","DOI":"10.1016\/j.jacc.2015.12.022"},{"key":"87","unstructured":"87. WL Gore and Associates. GORE<sup>\u00ae<\/sup> HELEX<sup>\u00ae<\/sup> septal occluder GORE<sup>\u00ae<\/sup> septal occluder for patent foramen ovale (PFO) closure in stroke patients: The Gore REDUCE Clinical Study. 2017. https:\/\/ClinicalTrials.gov\/show\/NCT00738894 (acessed May 30, 2016)."}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/8\/80_CJ-16-0534\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:50:45Z","timestamp":1498308645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/8\/80_CJ-16-0534\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":87,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-16-0534","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}